Search hospitals > Ohio > Youngstown
Saint Elizabeth Youngstown Hospital
Claim this profileYoungstown, Ohio 44504
Global Leader in Thyroid Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Stomach Cancer
111 reported clinical trials
3 medical researchers
Summary
Saint Elizabeth Youngstown Hospital is a medical facility located in Youngstown, Ohio. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Stomach Cancer and other specialties. Saint Elizabeth Youngstown Hospital is involved with conducting 111 clinical trials across 276 conditions. There are 3 research doctors associated with this hospital, such as Howard M. Gross, James Kim, MD, and jawad Francis.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Howard M. GrossKettering Medical Center6 years of reported clinical research
Expert in Thyroid Cancer
Expert in Breast Cancer
134 reported clinical trials
199 drugs studied
James Kim, MDSaint Elizabeth Youngstown Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
1 reported clinical trial
1 drug studied
jawad FrancisSt. Elizabeth Youngstown Hospital2 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
5 drugs studied
Clinical Trials running at Saint Elizabeth Youngstown Hospital
Breast Cancer
Lung Cancer
Bladder Cancer
Thyroid Cancer
Breast cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Skin Cancer
Multiple Myeloma
Cutaneous Melanoma
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Elizabeth Youngstown Hospital?
Saint Elizabeth Youngstown Hospital is a medical facility located in Youngstown, Ohio. This center is recognized for care of Thyroid Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Stomach Cancer and other specialties. Saint Elizabeth Youngstown Hospital is involved with conducting 111 clinical trials across 276 conditions. There are 3 research doctors associated with this hospital, such as Howard M. Gross, James Kim, MD, and jawad Francis.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.